Literature DB >> 17467279

Parkin and synphilin-1 isoform expression changes in Lewy body diseases.

Jordi Humbert1, Katrin Beyer, Cristina Carrato, José L Mate, Isidro Ferrer, Aurelio Ariza.   

Abstract

Alternative splicing gives rise to at least seven parkin and eight synphilin-1 isoforms. Since both parkin and synphilin-1 have been involved in Lewy body (LB) formation, we decided to explore whether their isoforms are differentially expressed in LB diseases. With this aim, we studied relative mRNA expression levels of parkin and synphilin-1 isoforms in the frontal cortices of patients with dementia with LBs, the LB variant of Alzheimer's disease and Parkinson's disease and compared the findings with those obtained from Alzheimer's disease patients and control individuals. Duplex real-time PCR reactions, with beta-actin as internal standard, were carried out in a LightCycler. mRNA expression levels of parkin and synphilin-1 isoforms were seen to be specifically altered in each of the LB diseases studied. These findings suggest that parkin and synphilin-1 isoform expression changes play a significant role in the pathogenesis of LB diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467279     DOI: 10.1016/j.nbd.2007.03.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  15 in total

1.  Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Rita Reitano; Sebastiano Cavallaro; Velia D'Agata
Journal:  Protein J       Date:  2016-10       Impact factor: 2.371

2.  New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases.

Authors:  Katrin Beyer; Ana M Munoz-Marmol; Carolina Sanz; Ruth Marginet-Flinch; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2011-12-29       Impact factor: 2.660

3.  Expression pattern of parkin isoforms in lung adenocarcinomas.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Gaetano Magro; Lucia Salvatorelli; Filippo Drago; Velia D'Agata
Journal:  Tumour Biol       Date:  2015-02-06

4.  Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sábat; José I Lao; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2007-10-23       Impact factor: 2.660

5.  Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Jordi Humbert; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2008-03-12       Impact factor: 2.660

6.  Parkin promotes intracellular Abeta1-42 clearance.

Authors:  Mark P Burns; Lihua Zhang; G William Rebeck; Henry W Querfurth; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

7.  Neuronal gene expression correlates of Parkinson's disease with dementia.

Authors:  Chelsea Stamper; Andrew Siegel; Winnie S Liang; John V Pearson; Dietrich A Stephan; Holly Shill; Don Connor; John N Caviness; Marwan Sabbagh; Thomas G Beach; Charles H Adler; Travis Dunckley
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

8.  Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels.

Authors:  Angel Carvajal-Oliveros; Carmen Domínguez-Baleón; Rafaella V Zárate; Jorge M Campusano; Verónica Narváez-Padilla; Enrique Reynaud
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

9.  Molecular determinants of selective clearance of protein inclusions by autophagy.

Authors:  Esther Wong; Eloy Bejarano; Moumita Rakshit; Karen Lee; Hugo H Hanson; Nava Zaarur; Greg R Phillips; Michael Y Sherman; Ana Maria Cuervo
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 10.  Molecular pathology of Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Aurelio Ariza
Journal:  Int J Mol Sci       Date:  2009-02-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.